IDH1 and cancer: IDH1/2 mutations that are associated with cancer tend to localize to the arginine (R) residue that is crucial for the recognition of isocitrate (R132 for IDH1, R140 or R172 for IDH2), with a vast majority of IDH1 R132H events [7].